Pure H20 Bio-Technologies, Inc. Announces Existing Water Treatment Has Its Limitations

  
    
  
  
    
      Pure H2O Bio-Technologies, Inc. (Pink Sheets: 
      PRHB) announced today Existing Water Treatment Has Its Limitations. Pure 
      H20 Bio-Technologies, Inc. is focused on the 
      continued development of water disinfection technology that provides an 
      added, but crucial layer of protection for individuals, homeowners, 
      businesses and healthcare facilities.
    
    
      The Company's water disinfection systems are based on highly innovative 
      disinfection and filtration removal that targets the principal 
      pathogens, such as Cryptosporidium, Giardia, and the deadly E.coli 
      strain 0157, which are resistant to conventional disinfectants, such as 
      chlorine and other halogen compounds. Recent testing proved that PRHB's 
      new primary disinfectant agent TTOT (tetrasilver-tetraoxide) is highly 
      effective for killing these problematic organisms.
    
    
      Our nation's public drinking water is not as safe as it should be. Water 
      treatment facilities, although operated correctly and remove the vast 
      majority of microbial contaminants, can be breached by some recently 
      emerging pathogens, as evidenced by the number of waterborne disease 
      outbreaks, some of which affected thousands of people. In 2005, there 
      were 7,212 cases of cryptosporidiosis; 17,256 cases of giardiasis; 2,368 
      cases of E.coli 0175:H7; 9,877 cases of hepatitis; and 1,952 cases of 
      legionellosis, proving the threat of outbreaks still exists. In 
      addition, biofilms have been found on almost every submerged surface in 
      treatment plants and distribution systems according to the NSF Center 
      for Biofilm Engineering (2000).
    
    
      Pure H2O will capitalize on the need for improved point-of-entry and 
      point-of-use water treatment systems and on the need for a disinfection 
      system that has the overall capacity for treating the emerging threat of 
      agents that are not killed by halogen-based/filtration systems.
    
    
      The Company's elite team of microbiologists and engineers, together with 
      its founder and President, Joseph P. Doxey, achieved outstanding results 
      in the research, design and development of PRHB's water disinfection 
      products. PRHB is poised to be a leader in the industry by being ahead 
      of the curve in water disinfection.
    
    
      "We set out to achieve an objective to provide a solution to a global 
      concern, unsafe drinking water. Our team of professionals dedicated 
      themselves to reach that objective and we are proud to say we have a 
      superior product to submit to NSF for certification," said Joseph P. 
      Doxey, President.
    
    
      About Pure H20 Bio-Technologies, Inc.:
    
    
      Pure H20 Bio-Technologies, Inc. is a publicly 
      held company specializing in the manufacturing, design and sale of its 
      unique residential, commercial and hospital point-of-use potable water 
      disinfection systems. These systems are specifically designed to work 
      effectively against water-borne pathogens and remove heavy metals and 
      objectionable biomass.
    
    
      The foregoing press release contains forward-looking statements that can 
      be identified by such terminology as "expects," "potential," "suggests," 
      "may," "intends," or similar expressions. Such forward-looking 
      statements involve known and unknown risks, uncertainties, and other 
      factors that may cause the actual results to be materially different 
      from any future results, performance or achievements expressed or 
      implied by such statements. In particular, management's expectations 
      regarding future research, development, and/or commercial results could 
      be affected by, among other things, uncertainties relating to the 
      availability of future financing; unexpected regulatory delays or 
      government regulation generally; the company's ability to obtain or 
      maintain patent and other proprietary intellectual property protection; 
      and completion in general. Forward-looking statements speak only as to 
      the date they were made. The company does not undertake to update 
      forward-looking statements to reflect circumstances or events that occur 
      after the date the forward-looking statements are made.